Investor perspective: Regulatory developments in the...

Privacy, Human Rights, new technologies Diversity,...

ESG integration is the new normal...

Hard and soft regulatory developments in...

Governance models, role and duty of...

SASB Biotech & Pharma standards revision...

Measuring and valuing Patient and Social...

Challenge of target-setting in the social...

The Biopharma Sustainability Roundtable (BSRT) and...

Roundtable Forum with Eco:Fact Update on...

Roundtable Forum with Lise Kingo Biopharma...

Connecting Biopharma Sustainability and Long-Term Planning...